George A. Samuel III insider trades
Open-market stock purchases and sales by George A. Samuel III, General Counsel and Secretary at Lineage Cell Therapeutics, Inc, from SEC Form 4 filings since Sep 1, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +98%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 5, 2026 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc | Sold (not open market) | $4.5K |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc | Sold (not open market) | $109 |
Companies traded
- LCTX Lineage Cell Therapeutics, Inc: 1 buy, last Mar 5, 2026
Get free alerts when George A. Samuel III files a new trade →